| Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point ZM Ndhlovu, P Kamya, N Mewalal, HN Kløverpris, T Nkosi, K Pretorius, ... Immunity 43 (3), 591-604, 2015 | 291 | 2015 |
| Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage DR Chopera, Z Woodman, K Mlisana, M Mlotshwa, DP Martin, C Seoighe, ... PLoS pathogens 4 (3), e1000033, 2008 | 175 | 2008 |
| Pharmacogenomics implications of using herbal medicinal plants on African populations in health transition NE Thomford, K Dzobo, D Chopera, A Wonkam, M Skelton, D Blackhurst, ... Pharmaceuticals 8 (3), 637-663, 2015 | 133 | 2015 |
| African-led health research and capacity building-is it working? VO Kasprowicz, D Chopera, KD Waddilove, MA Brockman, J Gilmour, ... BMC Public Health 20, 1-10, 2020 | 118 | 2020 |
| Fibroblast-derived extracellular matrix induces chondrogenic differentiation in human adipose-derived mesenchymal stromal/stem cells in vitro K Dzobo, T Turnley, A Wishart, A Rowe, K Kallmeyer, FA Van Vollenstee, ... International journal of molecular sciences 17 (8), 1259, 2016 | 70 | 2016 |
| Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses G Hancock, H Yang, E Yorke, E Wainwright, V Bourne, A Frisbee, ... PLoS pathogens 11 (2), e1004658, 2015 | 59 | 2015 |
| Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic LA Cotton, XT Kuang, AQ Le, JM Carlson, B Chan, DR Chopera, ... PLoS genetics 10 (4), e1004295, 2014 | 49 | 2014 |
| Inhibition of CYP2B6 by medicinal plant extracts: implication for use of efavirenz and nevirapine-based highly active anti-retroviral therapy (HAART) in resource-limited settings NE Thomford, C Awortwe, K Dzobo, F Adu, D Chopera, A Wonkam, ... Molecules 21 (2), 211, 2016 | 42 | 2016 |
| Subtype-specific differences in Gag-protease-driven replication capacity are consistent with intersubtype differences in HIV-1 disease progression MW Kiguoya, JK Mann, D Chopera, K Gounder, GQ Lee, PW Hunt, ... Journal of virology 91 (13), 10.1128/jvi. 00253-17, 2017 | 41 | 2017 |
| Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B* 58: 01-positive individuals DR Chopera, M Mlotshwa, Z Woodman, K Mlisana, D de Assis Rosa, ... Journal of virology 85 (14), 7070-7080, 2011 | 40 | 2011 |
| In Vitro Reversible and Time-Dependent CYP450 Inhibition Profiles of Medicinal Herbal Plant Extracts Newbouldia laevis and Cassia abbreviata: Implications for … NE Thomford, K Dzobo, D Chopera, A Wonkam, A Maroyi, D Blackhurst, ... Molecules 21 (7), 891, 2016 | 37 | 2016 |
| Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression M Mlotshwa, C Riou, D Chopera, D de Assis Rosa, R Ntale, F Treunicht, ... Journal of virology 84 (22), 12018-12029, 2010 | 37 | 2010 |
| Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity MA Brockman, DR Chopera, A Olvera, CJ Brumme, J Sela, TJ Markle, ... Journal of virology 86 (12), 6913-6923, 2012 | 34 | 2012 |
| Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure JK Mann, D Chopera, S Omarjee, XT Kuang, AQ Le, G Anmole, R Danroth, ... Virology 468, 214-225, 2014 | 33 | 2014 |
| Temporal association of HLA-B* 81: 01-and HLA-B* 39: 10-mediated HIV-1 p24 sequence evolution with disease progression RS Ntale, DR Chopera, NK Ngandu, D Assis de Rosa, L Zembe, ... Journal of virology 86 (22), 12013-12024, 2012 | 28 | 2012 |
| Immune-mediated attenuation of HIV-1 DR Chopera, JK Wright, MA Brockman, ZL Brumme Future virology 6 (8), 917-928, 2011 | 27 | 2011 |
| Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women V Naranbhai, D de Assis Rosa, L Werner, R Moodley, H Hong, ... BMC Infectious Diseases 16, 1-10, 2015 | 18 | 2015 |
| Protection mechanisms in the resurrection plant Xerophyta viscosa: cloning, expression, characterisation and role of XvINO1, a gene coding for a myo-inositol 1-phosphate synthase A Lehner, DR Chopera, SW Peters, F Keller, SG Mundree, JA Thomson, ... Functional Plant Biology 35 (1), 26-39, 2008 | 18 | 2008 |
| Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure ZL Brumme, DR Chopera, MA Brockman Current Opinion in Virology 2 (5), 599-605, 2012 | 17 | 2012 |
| Early immune adaptation in HIV-1 revealed by population-level approaches E Martin, JM Carlson, AQ Le, DR Chopera, R McGovern, MA Rahman, ... Retrovirology 11, 1-16, 2014 | 16 | 2014 |
